Chemical and Pharmaceutical Bulletin p. 2096 - 2099 (1997)
Update date:2022-08-06
Topics:
Takeuchi, Yasuo
Kitaomo, Masayuki
Chang, Ming-Rong
Shirasaka, Shota
Shimamura, Chinami
Okuno, Yumiko
Yamato, Masatoshi
Harayama, Takashi
Indolo[3,2-b]quinoline derivatives (1b-i) with a methyl group at each possible position have been synthesized. The 1-methyl (1b) and 9-methyl (1i) derivatives were inactive, but the 3-methyl (1d), 4-methyl (1e), and 6- methyl (1f) derivatives exhibited high treatment/control (T/C) value and cure rates against leukemia P388 in mice. These results indicated that modification of indolo[3,2-b]quinoline derivatives at 3, 4, and 6 positions may be useful approach for lead optimization.
View MoreAnhui Sunsing Chemicals Co.,Ltd
website:http://www.sunsingchem.com
Contact:0086-566-2023179
Address:Jin An industry park, Chizhou economic technical development zone, Anhui
Chongqing Rong＆Quan Pharmaceutical Technology Co. , Ltd.
Contact:86-023-65268721
Address:No. 7, Manshanhong Village, Pingdingshan, Shapingba District, Chongqing Province, China
Taizhou Elitechemie MediPharma Technology Co.,Ltd.
Contact:+86-523-86810021
Address:Building G14,NO.1 Avenue,China Medical City, Taizhou, Jiangsu,China
Xi'an Unique Electronic and Chemical Co., Ltd.
Contact:+86-029-88238008
Address:1703# B BUILDING WEST ELECTRONIC ZONE, XI'AN, CHINA
Jinhua City Mingzhu Pharmaceutical Co.,Ltd.
Contact:15857995878 0579-82207761
Address:No.169 Shenze Road, New Area,Jinpan Development Zone, Jinhua
Doi:10.1016/j.tetlet.2011.04.036
(2011)Doi:10.1016/j.crci.2010.11.001
(2011)Doi:10.1002/adsc.201000927
(2011)Doi:10.1039/c1ob05571b
(2011)Doi:10.1039/c5cc06712j
(2016)Doi:10.1016/j.bbagen.2011.03.001
(2011)
